Corbus pharmaceuticals holdings, inc. (CRBP)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Dec'13
ASSETS
Current assets:
Cash and cash equivalents

46,617

31,748

54,849

73,154

89,919

41,748

55,659

64,676

70,955

62,537

36,597

43,032

48,927

14,992

18,909

22,025

9,687

12,338

13,172

9,243

4,971

6,262

7,536

303

Restricted cash

-

-

-

-

-

-

0

0

0

158

200

150

150

150

-

-

-

0

-

-

-

-

-

-

Grants receivable

-

-

-

-

-

-

-

-

-

-

500

0

0

1,000

-

-

-

0

-

-

-

-

-

-

Stock subscriptions receivable

-

-

-

-

-

-

-

-

-

-

0

0

0

330

-

-

-

0

-

-

-

-

-

-

Prepaid expenses and other current assets

3,596

3,724

2,685

2,235

2,904

2,491

-

-

-

-

719

844

-

930

-

-

-

-

-

-

-

-

-

-

Contract asset

4,443

2,681

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

2,800

2,876

3,531

2,808

-

-

1,070

-

315

274

474

376

98

249

210

270

20

2

Total current assets

54,657

38,154

57,535

75,390

92,824

44,240

58,459

67,552

74,486

65,504

38,017

44,027

50,147

17,402

19,225

22,299

10,162

12,714

13,271

9,492

5,182

6,533

7,556

305

Restricted cash

-

-

-

-

-

-

-

-

-

-

0

50

50

50

186

36

36

36

13

13

13

13

13

-

Property and equipment, net

4,851

5,083

4,891

2,912

2,694

2,705

2,702

2,671

2,593

1,432

337

418

409

435

345

291

296

124

48

58

50

54

59

-

Operating lease right of use assets

5,680

5,818

5,569

5,695

5,839

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

14

84

134

123

35

43

19

64

59

40

65

65

-

0

-

-

-

-

-

-

-

-

-

-

Total assets

65,203

49,142

68,130

84,122

101,393

46,989

61,181

70,288

77,139

66,978

38,419

44,561

50,607

17,888

19,756

22,627

10,495

12,875

13,333

9,564

5,246

6,600

7,629

305

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

Notes payable

432

752

-

99

247

394

0

83

208

332

0

39

155

271

0

23

92

162

-

-

72

144

75

306

Accounts payable

9,960

11,091

6,193

7,490

8,962

6,345

6,153

3,081

4,169

3,130

3,776

3,859

3,266

3,419

2,768

1,962

1,230

1,314

728

1,069

188

344

482

181

Accounts payable-related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

200

-

-

-

-

Accrued interest payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

77

Accrued expenses

23,516

22,447

23,969

19,056

15,563

9,851

7,385

5,804

5,898

4,741

2,558

2,705

2,874

3,256

2,342

1,915

1,297

562

466

390

293

249

55

63

Deferred revenue, current

-

-

-

-

-

1,462

3,389

4,480

-

-

0

296

646

1,940

1,315

1,058

1,455

1,591

681

681

-

-

-

-

Deferred revenue

-

-

-

2,482

27,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities, current

742

595

386

312

266

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent, current

-

-

-

-

-

35

-

-

-

-

0

12

12

10

-

-

-

0

-

-

-

-

-

-

Total current liabilities

34,652

34,887

30,549

29,441

52,040

18,089

16,928

13,450

10,276

8,204

6,335

6,913

6,955

8,898

6,427

4,958

4,076

3,630

1,875

2,340

554

738

613

648

Operating lease liabilities, noncurrent

7,859

8,097

7,940

7,307

7,051

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, noncurrent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

260

284

454

-

-

-

-

Deferred rent, noncurrent

-

-

-

-

-

1,375

1,382

1,352

1,323

989

102

58

62

65

-

-

-

0

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

0

0

0

0

1

2

3

4

15

15

14

0

-

-

-

-

-

-

Notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

331

Total liabilities

42,512

42,984

38,489

36,748

59,092

19,465

18,310

14,803

11,600

9,194

6,439

6,974

7,021

8,968

6,442

4,974

4,091

3,890

2,160

2,795

554

738

613

980

Commitments and Contingencies

-

-

-

-

-

-

0

0

-

-

0

0

0

0

-

-

0

-

0

0

0

0

0

0

Stockholders' equity
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.0001 par value; 150,000,000 shares authorized, 72,490,449 and 64,672,893 shares issued and outstanding at March 31, 2020 and December 31, 2019

7

6

6

6

6

5

5

5

5

5

5

5

5

4

4

4

3

3

3

3

2

2

2

0

Additional paid-in capital

-

-

-

-

-

-

146,929

144,942

142,927

123,476

86,979

85,620

84,322

42,191

39,016

38,008

22,570

22,259

-

-

-

10,287

-

-

Additional paid-in capital

245,164

198,975

195,877

192,819

189,899

148,888

-

-

-

-

-

-

-

-

-

-

-

-

21,949

15,291

10,651

-

10,180

102

Accumulated deficit

-222,480

-192,823

-166,243

-145,452

-147,605

-121,370

-104,064

-89,462

-77,393

-65,698

-55,004

-48,038

-40,741

-33,276

-25,706

-20,359

-16,170

-13,277

-10,779

-8,525

-5,962

-4,427

-3,166

-1,886

Total stockholders' equity

22,691

6,157

29,640

47,373

42,300

27,524

42,870

55,485

65,539

57,783

31,980

37,586

43,586

8,919

13,314

17,653

6,404

8,985

11,173

6,769

4,691

5,862

7,015

-1,783

Total liabilities and stockholders' equity

65,203

49,142

68,130

84,122

101,393

46,989

61,181

70,288

77,139

66,978

38,419

44,561

50,607

17,888

19,756

22,627

10,495

12,875

13,333

9,564

5,246

6,600

7,629

305